PROLINES AND AMYLOIDOGENICITY IN FRAGMENTS OF THE ALZHEIMERS PEPTIDE BETA/A4

被引:310
作者
WOOD, SJ [1 ]
WETZEL, R [1 ]
MARTIN, JD [1 ]
HURLE, MR [1 ]
机构
[1] SMITHKLINE BEECHAM PHARMACEUT,DEPT MACROMOLEC SCI,KING OF PRUSSIA,PA 19406
关键词
D O I
10.1021/bi00003a003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although it is well accepted that the structure of amyloid fibrils is dominated by some form of antiparallel beta-sheet, there are few details on the secondary structural arrangements of the constituent peptides and how these peptides pack together in the fibril. We describe here the use of scanning proline mutagenesis to map the secondary structural roles of each residue in amyloidogenic peptide fragments of the Alzheimer's amyloid peptide beta/A4. In two series of fragments related to residues 15-23 and 12-26 of beta/A4, we show that Pro replacement of any residue in the amyloidogenic sequence LVFFAED, corresponding to residues 17-23, leads to essentially complete loss of fibril formation and to excellent peptide solubility. Since peptidyl-prolyl bonds are incapable of forming standard extended chain conformations, the results suggest that residues 17-23 make up the beta-sheet core of the fibrils formed by these fragments. In contrast to the proline replacements, alanine substitutions at residues 17, 18, and 20 have no effect on fibril formation, while replacement of Phe(19) reduces fibril formation to 15% of the level found for the wild type sequence. Scanning proline mutagenesis should play a useful role in mapping the secondary structural features of larger amyloidogenic peptide sequences, including longer, physiologically relevant forms of beta/A4. In addition, these results suggest explanations for some amyloidogenic effects observed in disease-related peptides and also suggest a possible role for aggregation-inhibiting insertion of prolines in protein evolution and protein design.
引用
收藏
页码:724 / 730
页数:7
相关论文
共 81 条
  • [1] REPLACEMENTS OF PRO86 IN PHAGE-T4 LYSOZYME EXTEND AN ALPHA-HELIX BUT DO NOT ALTER PROTEIN STABILITY
    ALBER, T
    BELL, JA
    DAOPIN, S
    NICHOLSON, H
    WOZNIAK, JA
    COOK, S
    MATTHEWS, BW
    [J]. SCIENCE, 1988, 239 (4840) : 631 - 635
  • [2] SOLUTION CONFORMATIONS AND AGGREGATIONAL PROPERTIES OF SYNTHETIC AMYLOID BETA-PEPTIDES OF ALZHEIMERS-DISEASE - ANALYSIS OF CIRCULAR-DICHROISM SPECTRA
    BARROW, CJ
    YASUDA, A
    KENNY, PTM
    ZAGORSKI, MG
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1992, 225 (04) : 1075 - 1093
  • [3] AMYLOIDOSIS RELATED TO A LAMBDA-IV IMMUNOGLOBULIN LIGHT CHAIN PROTEIN
    BENSON, MD
    DWULET, FE
    MADURA, D
    WHEELER, G
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1989, 29 (02) : 175 - 179
  • [4] Benson MD, 1989, METABOLIC BASIS INHE, P2439
  • [5] BONAR L, 1969, P SOC EXP BIOL MED, V131, P1373
  • [6] AMYLOID-LIKE PROPERTIES OF A SYNTHETIC PEPTIDE CORRESPONDING TO THE CARBOXY TERMINUS OF BETA-AMYLOID PROTEIN-PRECURSOR
    CAPUTO, CB
    FRASER, PE
    SOBEL, IE
    KIRSCHNER, DA
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 292 (01) : 199 - 205
  • [7] CASTANO EM, 1988, LAB INVEST, V58, P122
  • [8] INVITRO FORMATION OF AMYLOID FIBRILS FROM 2 SYNTHETIC PEPTIDES OF DIFFERENT LENGTHS HOMOLOGOUS TO ALZHEIMERS-DISEASE BETA-PROTEIN
    CASTANO, EM
    GHISO, J
    PRELLI, F
    GOREVIC, PD
    MIGHELI, A
    FRANGIONE, B
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 141 (02) : 782 - 789
  • [9] CHOU PY, 1973, BIOCHEMISTRY-US, V13, P211
  • [10] CLARK AH, 1981, INT J PEPT PROT RES, V17, P353